Skip to content

Memory Rehabilitation Strategies in Patients With Multiple Sclerosis

Strategies and Techniques for the Rehabilitation of Memory Deficits in Patients With Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05462678
Enrollment
60
Registered
2022-07-18
Start date
2018-09-01
Completion date
2021-11-20
Last updated
2022-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Cognitive Rehabilitation, Motor Rehabilitation, Cognitive Impairment

Brief summary

The clinical characteristics of MS are extremely variable from one patient to another. In about 60% of cases, motor disabilities are associated with cognitive deficits. The present study aims to compare three forms of cognitive / motor rehabilitation in three groups of patients with MS: rehabilitation of verbal memory with the Rehacom program; combined rehabilitation, associating a motor rehabilitation path with the Rehacom program; only motor rehabilitation course. Aims of the study will be: to verify whether the combined cognitive / motor rehabilitation can induce a significantly greater improvement in the memory performance of patients with MS compared to rehabilitation alone; check whether any improvement is objectively verifiable by patients and the impact it may have on patients' quality of life; monitor these effects after 6 months. For these purposes, three homogeneous groups of 20 patients each will be enrolled, diagnosed with MS according to Mc Donald's criteria revisited by Polman (2011). The study will be divided into an initial clinical, cognitive, emotional, quality of life and functional self-perception (T0) assessment. Subsequently, the patients assigned to the three conditions will be provided with the pre-established rehabilitation treatments for a total duration of 12 weeks; at the end, each patient will undergo an overall re-evaluation (T1). Finally, a further overall reassessment will be carried out after 6 months, aimed at follow-up monitoring (T2). Statistical analyzes will be of two types: Within Group (aimed at assessing any improvement in the cognitive performance of each group of patients by comparing the assessments at T0 with those at T1 and T2); Between Group (aimed at comparing the results obtained by each group with those of the other 2 groups at T0, T1, and T2).

Interventions

BEHAVIORALCognitive Rehabilitation

Each patient performed two weekly sessions of 45 minutes each, for 12 weeks

Each patient performed one session per week (45 minutes) of CR and one session per week of traditional MR training for 12 weeks.

Each patient performed two weekly sessions45 minutes each, for a total of 12 weeks.

Sponsors

I.R.C.C.S. Fondazione Santa Lucia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of MS defined according to McDonald's diagnostic criteria revised in 2011. * RRMS or SPMS phenotype. * Language Italian mother tongue. * EDSS score \<6.0

Exclusion criteria

* Neurological or psychiatric pathologies other than MS that can interfere with cognitive functioning * Clinical relapses in the three months prior to enrollment * Severe mental illness * Psychiatric disorders severe enough to interfere with cognitive functioning * Medications Steroid therapy in the 3 months prior to enrollment * Motor limitations Upper limb dysfunction (paralysis or tremor) that does not allow to hold the PC mouse * Sensory limitations Visual acuity impaired enough to not allow reading of the instructions to the various tests

Design outcomes

Primary

MeasureTime frameDescription
Pre- and Post treatment and long term cognitive efficiency9-monthsThe primary outcome of this study is the scores on the cognitive tasks (Minimal Assessment of Cognitive Functioning in Multiple Sclerosis -MACFIMS). For MACFIMS score ranges from 1 to 3 with higher scores corresponding to higher cognitive impairment.

Secondary

MeasureTime frameDescription
Pre- and Post-treatment and long term motor efficiency9-monthsThe secondary outcome of this study is the scores on the gait and balance efficiency scales (Tinetti Scale -TS); For TS the score ranges from 0 to 28 with higher scores corresponding to higher efficiency.

Other

MeasureTime frameDescription
Pre- and Post-treatment and long term disability and overall quality of life9-monthsTertiary outcome is the scores on the self-perceived quality of life assessed with World Health Organization Disability Assessment Schedule- WHO-DAS 2. For WHO-DAS 2 total score ranges from 0 to 100, with lower scores indicate lower levels of disability e better quality of life.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026